Although the pathogenic role of ET-1 in BPD is unclear and higher levels of ET-1 were expected in the moderate/severe BPD group, in our patients, we observed that lower levels of ET-1 in plasma were a risk factor, increasing the predictive value for the diagnosis of moderate or severe BPD. This evidence concerns the gene EDN1 and bronchopulmonary dysplasia.